- Home
- XBIT vs SENS Comparison
XBIT vs SENS Comparison
Compare XBIT & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XBIT | SENS |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.3M | 308.5M |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | XBIT | SENS |
|---|---|---|
| Price | $2.21 | $6.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $22.70 |
| AVG Volume (30 Days) | 26.0K | ★ 493.9K |
| Earning Date | 03-13-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $70.20 |
| Revenue Next Year | N/A | $59.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $2.09 | $0.41 |
| 52 Week High | $3.62 | $8.75 |
Technical Indicators
Market Signals| Indicator | XBIT | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 41.89 | 43.42 |
| Support Level | $2.15 | $5.46 |
| Resistance Level | $2.69 | $8.55 |
| Average True Range (ATR) | 0.10 | 0.54 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 26.98 | 33.55 |
Price Performance
Historical ComparisonAbout XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.